• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: STIMWAVE TECHNOLOGIES INC. STIMQ NEUROSTIMULATOR; PERIPHERAL NERVE STIMULATOR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

STIMWAVE TECHNOLOGIES INC. STIMQ NEUROSTIMULATOR; PERIPHERAL NERVE STIMULATOR Back to Search Results
Model Number STQ4-SPR-B0, STQ4-RCV-A0
Device Problem Material Erosion (1214)
Patient Problems Erosion (1750); Skin Infection (4544)
Event Date 01/05/2021
Event Type  Injury  
Manufacturer Narrative
The patient-reported attending a follow-up appointment with a primary care physician, who advised the patient to follow-up with the implanting clinician because the wound seemed to be infected and one of the leads appeared to be eroding.The patient reached out to the clinical representative immediately.The clinical representative recommended the patient call the implanting clinician's office and schedule a follow-up.On (b)(6) 2020, the patient was seen by one of the associates of the implanting clinician, who determined that the tail of the lead was protruding out of the patient's incision and recommended the leads be removed and re-implanted.The patient was instructed to follow-up with the implanting clinician on (b)(6) 2020, to discuss further options.On (b)(6) 2020, the implanting clinician told the patient that the plan is to explant and implant new leads immediately after bwc grants the approval.On (b)(6) 2021, the clinical representative was made aware by the patient that during a follow-up appointment on (b)(6) 2020, that the infection was found to be getting worse, and the implanting clinician explanted both leads and prescribed antibiotics (dosage, name, frequency unknown) to treat the infection.The implanting clinician plans to implant new stimulators once the infection has cleared.The procedure was reported to have been performed per the product ifu.Stimwave has confirmed that the product was delivered sterile, validated sterilization parameters were used, and sterile barriers were verified to be intact following packaging.The cause of the infection is no problem found.
 
Event Description
Complaint (b)(4) was received on (b)(6) 2020.The clinical representative was made aware that a recently implanted patient was suspect of potential infection and erosion at the wound site.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
STIMQ NEUROSTIMULATOR
Type of Device
PERIPHERAL NERVE STIMULATOR
Manufacturer (Section D)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer (Section G)
STIMWAVE TECHNOLOGIES INC.
1310 park central boulevard s.
pompano beach FL 33064
Manufacturer Contact
andrea najera
1310 park central boulevard s.
pompano beach, FL 33064
8009655134
MDR Report Key11301498
MDR Text Key230985472
Report Number3010676138-2021-00004
Device Sequence Number1
Product Code GZF
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K171366
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative
Reporter Occupation Nurse
Type of Report Initial
Report Date 02/09/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Lay User/Patient
Device Expiration Date03/01/2022
Device Model NumberSTQ4-SPR-B0, STQ4-RCV-A0
Device Lot NumberSWO200305, SWO200320
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 01/06/2021
Initial Date FDA Received02/09/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-